Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/1633
Title: | The apoptotic and anti-proliferative activity of Origanum majorana extracts on human leukemic cell line | Authors: | Abdel-Massih, Roula Fares, Rida Bazzi, Samer El-Chami, Nisrine Baydoun, Elias A-H. |
Affiliations: | Department of Biology Department of Biology |
Keywords: | Origanum majorana ALL Anti-proliferative Apoptosis DPPH |
Subjects: | Antioxidants | Issue Date: | 2010 | Part of: | Leukemia research | Volume: | 34 | Issue: | 8 | Start page: | 1052 | End page: | 1056 | Abstract: | Scientists are constantly searching for phytochemicals and compounds with anti-cancer and antioxidant activity. In this study, the anti-proliferative activity of plant extracts from Origanum majorana (marjoram) was tested on human lymphoblastic leukemia cell line Jurkat. Cytotoxicity was examined using non-radioactive cytotoxicity assay and the IC50 was calculated. At non-cytotoxic concentrations, the viability of cells decreased with increase of concentration of plant extract. The anti-proliferative effect was also found to be dose-dependent. Analysis via flow cytometry shows that marjoram extracts stimulated apoptosis. Induction of apoptosis was caused by an up-regulation of p53 protein levels and down-regulation of Bcl-2α. Marjoram exhibited a strong scavenging activity (SC50 = 0.03 mg dry weight). The conclusions from this study suggest that marjoram extracts exhibit anti-proliferative effect and high antioxidant activity. For that it merits further investigation as a potential therapeutic agent. |
URI: | https://scholarhub.balamand.edu.lb/handle/uob/1633 | DOI: | 10.1016/j.leukres.2009.09.018 | Ezproxy URL: | Link to full text | Type: | Journal Article |
Appears in Collections: | Department of Biology |
Show full item record
SCOPUSTM
Citations
61
checked on Nov 16, 2024
Record view(s)
56
checked on Nov 21, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.